ATyr Pharma to Present at Upcoming Investor Conferences

GlobeNewswire10/31 20:00

With 64% Ownership in ATyr Pharma, Inc. (NASDAQ:ATYR), Institutional Investors Have a Lot Riding on the Business

Simply Wall St10/16 21:08

ATyr Pharma's Lead Therapeutic Candidate Efzofitimod For Pulmonary Sarcoidosis To Be Featured In Best Of CHEST Journals At CHEST 2024 Annual Meeting October 6 – 9, 2024

Benzinga10/08 20:10

ATyr Pharma ATYR Phase 1b/2a Data; Summit SMMT Enrollment Completed

BioPharmCatalyst10/04 20:11

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga10/04 20:07

Wells Fargo Initiates ATyr Pharma Overweight With $17 Price Target

MT Newswires10/04 18:48